Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.

John Z. Metcalfe,Salome Makumbirofa,Beauty Makamure,Charles Sandy,Wilbert Bara,Peter R. Mason,Philip C. Hopewell

Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.

2016

John Z. Metcalfe
Salome Makumbirofa
Beauty Makamure
Charles Sandy
Wilbert Bara
Peter R. Mason
Philip C. Hopewell

Background Patients at elevated risk of drug-resistant tuberculosis are prioritized for testing with Xpert MTB/RIF® (“Xpert”), though clinical utility in this population is understudied.

Keywords:

Molecular diagnostic techniques
Mycobacterium tuberculosis
Population
Tuberculosis
Immunology
DNA Mutational Analysis
Virology
Predictive value of tests
Medicine
rifampin resistance
rpoB
time to treatment
Internal medicine
Prospective cohort study

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations